Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Charles S. Fuchs(Dana-Farber Cancer Institute), Jiří Tomášek(Masaryk Memorial Cancer Institute), Cho Jae Yong(Yonsei University), Filip Dumitru(County Hospital), Rodolfo Passalacqua(Istituti Ospitalieri di Cremona), Chanchal Goswami(Medical College and Hospital, Kolkata), Howard Safran(Brown University), Lucas Vieira dos Santos(Hospital de Câncer de Barretos), Giuseppe Aprile(University of Udine), David Ferry(New Cross Hospital), Bohuslav Melichar(Palacký University Olomouc), Mustapha Tehfé(Hôpital Notre-Dame), Э. Э. Топузов(Ural State Medical University), John Zalcberg(The University of Melbourne), Ian Chau(Royal Marsden Hospital), William Campbell, Choondal Devan Sivanandan(Regional Cancer Center, Thiruvananthapuram), Joanna Pikiel(Centrum Onkologii), Minori Koshiji, Yanzhi Hsu, Astra M. Liepa(Eli Lilly (United States)), Ling Gao, Jonathan D. Schwartz, Josep Tabernero(Universitat Autònoma de Barcelona)
Cited by 2,195Open Access
Abstract
Related Papers
Chemotherapy for advanced gastric cancer
Dorothea Wagner, Nicholas Syn, Markus Moehler et al.|Cochrane Database of Systematic Reviews|2017|1.3k